There is not yet published data to demonstrate the role of IL-38 in intestinal mucosal infection, but significantly upregulated circulating IL-38 from COVID-19 patients with severe lung viral infection of SARS-Cov2 has been reported and is of interest, since lung and gut are both mucosal associated lymphoid organs (27). Here, IL1F10 is linked to COVID-19.